Interethnic differences in omeprazole metabolism in the two S-mephenytoin hydroxylation phenotypes studied in Caucasians and Orientals
- PMID: 8009572
- DOI: 10.1097/00007691-199404000-00018
Interethnic differences in omeprazole metabolism in the two S-mephenytoin hydroxylation phenotypes studied in Caucasians and Orientals
Abstract
Two independent studies showed that the 5-hydroxylation, but not the sulfoxidation, of omeprazole is more rapid in extensive metabolizers (EMs) than in poor metabolizers (PMs) of S-mephenytoin. In Caucasian, Chinese, and Korean PMs, the mean oral clearances were similar and not significantly different (85, 73, and 59 ml h-1 kg-1, respectively). However, the geometric mean clearance in Caucasian EMs (950 ml h-1 kg-1) was higher than in both Chinese EMs (426 ml h-1 kg-1, p < 0.05) and Korean EMs (446 ml h-1 kg-1, p < 0.01). The incidence of PMs of S-mephenytoin is higher in Chinese (14.6%) and Koreans (12.6%) than in Swedish Caucasians (3.3%). Therefore, the proportion of heterozygous compared to homozygous EMs is higher in Orientals than in Caucasians. This might explain the higher clearance of omeprazole in Caucasian EMs compared to the clearance of omeprazole in Chinese and Korean EMs of S-mephenytoin.
Similar articles
-
Geographical/interracial differences in polymorphic drug oxidation. Current state of knowledge of cytochromes P450 (CYP) 2D6 and 2C19.Clin Pharmacokinet. 1995 Sep;29(3):192-209. doi: 10.2165/00003088-199529030-00005. Clin Pharmacokinet. 1995. PMID: 8521680 Review.
-
Use of omeprazole as a probe drug for CYP2C19 phenotype in Swedish Caucasians: comparison with S-mephenytoin hydroxylation phenotype and CYP2C19 genotype.Pharmacogenetics. 1995 Dec;5(6):358-63. doi: 10.1097/00008571-199512000-00004. Pharmacogenetics. 1995. PMID: 8747407
-
Polymorphic hydroxylation of S-mephenytoin and omeprazole metabolism in Caucasian and Chinese subjects.Pharmacogenetics. 1992 Feb;2(1):25-31. doi: 10.1097/00008571-199202000-00005. Pharmacogenetics. 1992. PMID: 1302040
-
5-hydroxylation of omeprazole by human liver microsomal fractions from Chinese populations related to CYP2C19 gene dose and individual ethnicity.J Pharmacol Exp Ther. 2000 Nov;295(2):844-51. J Pharmacol Exp Ther. 2000. PMID: 11046127
-
[The molecular mechanism of polymorphism of S-mephenytoin hydroxylative metabolism].Sheng Li Ke Xue Jin Zhan. 1995 Jan;26(1):23-8. Sheng Li Ke Xue Jin Zhan. 1995. PMID: 7604218 Review. Chinese.
Cited by
-
Efficacy and safety of oral SOCG in treatment of major depressive disorder: A protocol for a phase II, randomized, double-blind, placebo controlled, parallel-groups, dose finding exploratory study.Medicine (Baltimore). 2019 Aug;98(35):e16854. doi: 10.1097/MD.0000000000016854. Medicine (Baltimore). 2019. PMID: 31464912 Free PMC article. Clinical Trial.
-
Geographical/interracial differences in polymorphic drug oxidation. Current state of knowledge of cytochromes P450 (CYP) 2D6 and 2C19.Clin Pharmacokinet. 1995 Sep;29(3):192-209. doi: 10.2165/00003088-199529030-00005. Clin Pharmacokinet. 1995. PMID: 8521680 Review.
-
Efficacy of tailored Helicobacter pylori eradication therapy based on antibiotic susceptibility and CYP2C19 genotype.World J Gastroenterol. 2014 Jun 7;20(21):6400-11. doi: 10.3748/wjg.v20.i21.6400. World J Gastroenterol. 2014. PMID: 24914361 Free PMC article. Review.
-
Appropriate first-line regimens to combat Helicobacter pylori antibiotic resistance: an Asian perspective.Molecules. 2015 Apr 8;20(4):6068-92. doi: 10.3390/molecules20046068. Molecules. 2015. PMID: 25856059 Free PMC article. Review.
-
Efficacy of S-pantoprazole 20 mg compared with pantoprazole 40 mg in the treatment of reflux esophagitis: a randomized, double-blind comparative trial.Dig Dis Sci. 2012 Dec;57(12):3189-94. doi: 10.1007/s10620-012-2297-y. Epub 2012 Jul 8. Dig Dis Sci. 2012. PMID: 22772870 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources